The global pharmaceutical industry experienced a 23% rise in company filings mentions of internet of things in Q2 2023 compared with the previous quarter, with the highest share accounted for by Sarepta Therapeutics, according to GlobalData’s analysis of over 72 pharmaceutical company filings. The growing application of Internet of Things will prove to have a transformative impact across the Healthcare sector. GlobalData’s Internet of Things market report helps keep abreast of the latest trends in Internet of Things, market opportunity forecast and the competitive landscape. Buy the report here.
Notably, internet of things was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of sharing economy and governance, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Sarepta Therapeutics had the greatest increase in references for internet of things in Q2 2023, compared with the previous quarter. GlobalData identified one internet of things-related sentences in the company's filings - 0.1% of all sentences - and an increase of 100% in Q2 2023 compared with Q2 2022.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for internet of things in Q2 2023 was 94.
To further understand GlobalData's analysis on Internet of Things market, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.